<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>21(1)</volume><submitter>Gong Q</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>The global status of the COVID-19 pandemic is not optimistic. This is a particularly vulnerable time for patients with pre-existing headache disorders. The present study aimed to investigate the impact of the COVID-19 pandemic on headache patients in China.&lt;h4>Methods&lt;/h4>A survey was conducted through an online survey platform on June 6, 2020. Demographic characteristics, the PHQ-9, the ISI, a COVID-19 questionnaire and a headache profile survey were included in the online questionnaire.&lt;h4>Results&lt;/h4>Eventually, a total of 15,000 participants from China completed the online questionnaire. Among them, 2806 participants had pre-existing headache disorders. Our analysis showed reductions in the duration of headaches (3.414 ± 6.859 vs 4.033 ± 7.325 h, P&lt;0.001), number of </pubmed_abstract><journal>BMC neurology</journal><pagination>224</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8203488</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Overall trend towards headache remission during the COVID-19 pandemic among Chinese patients with pre-existing headache highlights the role of family support.</pubmed_title><pmcid>PMC8203488</pmcid><pubmed_authors>Yao L</pubmed_authors><pubmed_authors>Gong Q</pubmed_authors><pubmed_authors>Xiao Z</pubmed_authors><pubmed_authors>Liu S</pubmed_authors><pubmed_authors>Li R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Overall trend towards headache remission during the COVID-19 pandemic among Chinese patients with pre-existing headache highlights the role of family support.</name><description>&lt;h4>Background&lt;/h4>The global status of the COVID-19 pandemic is not optimistic. This is a particularly vulnerable time for patients with pre-existing headache disorders. The present study aimed to investigate the impact of the COVID-19 pandemic on headache patients in China.&lt;h4>Methods&lt;/h4>A survey was conducted through an online survey platform on June 6, 2020. Demographic characteristics, the PHQ-9, the ISI, a COVID-19 questionnaire and a headache profile survey were included in the online questionnaire.&lt;h4>Results&lt;/h4>Eventually, a total of 15,000 participants from China completed the online questionnaire. Among them, 2806 participants had pre-existing headache disorders. Our analysis showed reductions in the duration of headaches (3.414 ± 6.859 vs 4.033 ± 7.325 h, P&lt;0.001), number of </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jun</publication><modification>2025-04-04T20:58:15.594Z</modification><creation>2022-02-10T18:05:00.671Z</creation></dates><accession>S-EPMC8203488</accession><cross_references><pubmed>34130634</pubmed><doi>10.1186/s12883-021-02216-6</doi></cross_references></HashMap>